Market Cap (In INR)
34.37 Billion
Revenue (In INR)
1.69 Billion
Net Income (In INR)
591.63 Million
Avg. Volume
81.38 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 72.45-312.85
- PE
- 65.18
- EPS
- 4.84
- Beta Value
- 0.74051946
- ISIN
- INE942C01045
- CUSIP
- -
- CIK
- -
- Shares
- 108965260.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Tapas B. Guhathakurata
- Employee Count
- -
- Website
- http://www.gtbl.in
- Ipo Date
- 2002-01-02
- Details
- Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.
More Stocks
-
EFCILEFC (I) LIMITED
EFCIL
-
ISTRNETWKiStreet Network Limited
ISTRNETWK
-
300830
-
GNA
-
2477Temairazu, Inc.
2477
-
RRILRRIL LIMITED
RRIL
-
IMMOImmotion Group Plc
IMMO
-
ZTE